查看购物车
  • Traditional Chinese
  • English
  • Japanese
週边血管器械市场：按类型（血管成形术支架、血管内动脉瘤修復血管支架、导管、IVC 过滤器、血管成形术球囊、斑块移除装置、血流动力学改变装置、其他）、按地区- 预测至2029 年
市场调查报告书
商品编码
1567385

週边血管器械市场：按类型（血管成形术支架、血管内动脉瘤修復血管支架、导管、IVC 过滤器、血管成形术球囊、斑块移除装置、血流动力学改变装置、其他）、按地区- 预测至2029 年

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 324 Pages | 订单完成后即时交付

价格

全球週边血管器械市场规模预计将从2024年的114.3亿美元增加到2029年的147.3亿美元，2024年至2029年的复合年增长率为5.2%。

由于PAD和DVT等血管疾病的盛行率不断上升，週边血管器械市场正在迅速扩大。人口老化、微创手术的增加以及支架、血管成形球囊和导管等血管技术的进步也是推动这一市场扩张的关键因素。人们对及时诊断和治疗方案以及政府支持措施的认识不断提高，进一步增加了市场需求。全球医疗基础设施的改善和血管诊所数量的增加正在推动市场的成长。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（百万美元）
按细分市场 按类型和地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

在周边血管器械市场中，主要用于血管成形术治疗的支架占有较高的份额。这是因为支架对于治疗 PAD 和 CAD 等疾病至关重要。支架设计用于在球囊血管成形术后需要维持动脉管腔时为血管提供长期支撑。与球囊和导管不同，支架不仅在手术过程中使用，而且是动脉狭窄的永久解决方案，减少血管再阻塞的机会。由于药物释放型支架 (DES) 和生物可吸收支架的技术进步，支架得到了普及，这些技术提高了支架的性能，包括减少併发症并改善长期预后。

支架也变得越来越受欢迎，因为与 EVAR（血管内动脉瘤修復术）等传统手术方法相比，它们具有微创性，可以缩短患者的康復时间，甚至缩短住院时间。此外，随着心血管疾病发病率和支架治疗的支付政策迅速朝着健康良性的方向发展，置入术正在发挥主导。此外，随着老年人口对重组的需求持续快速增加，血管成形术支架仍是周边血管装置的市场领导。

本报告研究了全球週边血管器械市场，包括按类型、地区和进入市场的公司概况分類的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 产业动态
  • 生态系分析
  • 价值链分析
  • 供应链分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 技术分析
  • 监管状况
  • 贸易分析
  • 价格分析
  • 报销分析
  • 专利分析
  • 2024-2025年重大会议和活动
  • 案例研究
  • 未满足的需求和最终用户的期望
  • 投资金筹措场景
  • 人工智慧对週边血管器械市场的影响

第六章 週边血管器械市场（按类型）

  • 介绍

第七章血管成形术支架市场（按类型）

  • 介绍
  • 药物释放型支架
  • 裸金属支架

第八章血管内动脉瘤修復血管支架市场（按类型）

  • 介绍
  • 腹部主动脉血管瘤血管支架
  • 胸主动脉瘤血管支架

第九章导管市场（按类型）

  • 介绍
  • 血管造影术导管
  • 引导管
  • IVUS/OCT 导管

第10章下腔静脉过滤器市场（按类型）

  • 介绍
  • 可回收过滤器
  • 永久过滤器

第十一章血管成形术球囊市场（按类型）

  • 介绍
  • 旧/普通气球
  • 药物释放型球囊
  • 气球切割和划线

第十二章斑块去除设备市场（按类型）

  • 介绍
  • 斑块切除装置
  • 血栓清除装置

第十三章血流调节器市场（依类型）

  • 介绍
  • 栓塞防护装置
  • 慢性全阻塞设备

第十四章其他週边血管器械市场（按类型）

  • 介绍
  • 导管导引线
  • 血管闭合装置
  • 导引鞘
  • 球囊扩张设备

第十五章 週边血管器械市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十六章竞争格局

  • 介绍
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 品牌/产品比较
  • 企业价值评估及财务指标
  • 竞争场景

第十七章 公司简介

  • 主要参与企业
    • BOSTON SCIENTIFIC CORPORATION
    • MEDTRONIC
    • ABBOTT
    • BECTON, DICKINSON AND COMPANY
    • TERUMO CORPORATION
    • B. BRAUN SE
    • MERIT MEDICAL SYSTEMS
    • PENUMBRA, INC.
    • KONINKLIJKE PHILIPS NV
    • STRYKER
    • CORDIS
    • COOK
    • WL GORE & ASSOCIATES, INC.
    • BIOSENSORS INTERNATIONAL GROUP, LTD.
    • IVASCULAR
    • BIOTRONIK
    • ENDOLOGIX
    • ENDOCOR GMBH & CO., KG
  • 其他公司
    • MERIL LIFE SCIENCES PVT. LTD.
    • ALVIMEDICA
    • CARDIONOVUM GMBH
    • SMT
    • MEDINOL
    • ANDRAMED GMBH
    • REX MEDICAL
    • QMD INC.
    • BROSMED MEDICAL CO., LTD.
    • ELIXIR MEDICAL

第十八章附录

Product Code: MD 1254

The global Peripheral vascular devices market is projected to reach USD 14.73 billion by 2029 from USD 11.43 billion in 2024, at a CAGR of 5.2% from 2024 to 2029. The market for peripheral vascular devices is sharply increasing in view of an increased prevalence of vascular diseases such as PAD and DVT. Other key drivers for this expansion are an aging population base, increased adoption of less-invasive procedures, and advancements in vascular technology in stents, angioplasty balloons, and catheters. Increased awareness about timely diagnosis and treatment options and supportive initiatives from the government further increase market demand. Improvement in global healthcare infrastructure and an increased number of specialized vascular clinics are adding to upward movement of the market.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsBy Type and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"By type segment Angioplasty stent to account for the largest share during the forecast period"

The peripheral vascular devices market offers a higher share of stents used in the treatment of angioplasty mainly because stenting is vital in managing diseases such as PAD and CAD. Stents are designed to give long-term vessel support where by the lumen of the arteries needs to be maintained after having a balloon angioplasty. Unlike balloons or catheters, stents are not used only during procedures; they are a permanent solution to the narrowing of an artery, decreasing the chances of restenosis. Technological advancements employing drug-eluting stents (DES) and bioresorbable stents have enhanced the capability of stents by lowering complications and yielding a better prognosis in the long term, therefore making it highly popular.

Stents are also increasingly gaining popularity because they are minimally invasive, where time towards recovery by patients and even the number of days spent in hospitals can be reduced compared to EVAR, or Endovascular Aneurysm Repair traditional surgical methods. Moreover, since the incidence of cardiovascular diseases and pay policies on stent procedures are rapidly moving in a healthy and benign direction, stent stints take the lead. Moreover, given the large geriatric population, where revascularization needs keep soaring, angioplasty stents remain the market leader for peripheral vascular devices.

"APAC is estimated to register the highest CAGR during the forecast period."

The Peripheral vascular devices market is divided into Five regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific region witnessed the highest CAGR during the forecast period. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. The increasing diabetic population and increase in obesity due to sedentary lifestyles reassesses also driving the growth of peripheral vascular devices in the APAC region.

The breakdown of the profile of primary participants in the peripheral vascular devices market:

  • By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
  • By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
  • By Region: North America - 40%, Europe - 30%, APAC -20%, Latin America - 5%,Middle East & Africa-5%

List of Companies Profiled in the Report

  • Boston scientific corporation(U.S)
  • Medtronic (U.S)
  • Abbott (U.S)
  • Becton, Dickinson, and Company(U.S)
  • Terumo Corporation (Japan)
  • B. Braun Melsungen AG(Germany)
  • Merit medical systems(U.S)
  • Penumbra, inc.(U.S)
  • Koninklijke Philips N.V..(Japan)

Research Coverage

This report studies the Peripheral vascular devices market based on type and region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Peripheral vascular devices market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

  • Analysis of key drivers (technological advancements), restraints (Cost of the system), challenges (regulatory policies), and opportunities (Increase in minimally invasive procedures) contributing to the growth of the Peripheral vascular devices market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Peripheral vascular devices market.
  • Market Development: Comprehensive information on the lucrative emerging markets type and region.
  • Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Peripheral vascular devices market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Peripheral vascular devices market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 LIMITATIONS
  • 1.5 MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW
  • 4.2 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE AND COUNTRY (2023)
  • 4.3 PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rapid growth in geriatric population and subsequent increase in disease prevalence
      • 5.2.1.2 Favorable reimbursement scenario for procedures
      • 5.2.1.3 Increased prevalence of diabetes
      • 5.2.1.4 Rising rate of tobacco consumption
      • 5.2.1.5 Growing incidence of obesity
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 High growth potential in emerging markets
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Availability of alternative treatments
      • 5.2.3.2 Dearth of skilled professionals with expertise in peripheral vascular devices
      • 5.2.3.3 Product failures and recalls
  • 5.3 INDUSTRY TRENDS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 PORTER'S FIVE FORCE ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS
    • 5.8.2 BUYING CRITERIA
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Drug-eluting stents
      • 5.9.1.2 Atherectomy devices
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Intravascular ultrasound
      • 5.9.2.2 Optical coherence tomography
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Remote patient monitoring
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 REGULATORY ANALYSIS
      • 5.10.1.1 North America
        • 5.10.1.1.1 US
        • 5.10.1.1.2 Canada
      • 5.10.1.2 Europe
      • 5.10.1.3 Asia Pacific
        • 5.10.1.3.1 Japan
        • 5.10.1.3.2 China
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA
    • 5.11.2 EXPORT DATA
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.12.2 AVERAGE SELLING PRICE, BY KEY PLAYERS
  • 5.13 REIMBURSEMENT ANALYSIS
  • 5.14 PATENT ANALYSIS
    • 5.14.1 PATENT PUBLICATION TRENDS
    • 5.14.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.15 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.16 CASE STUDIES
    • 5.16.1 CASE STUDY 1: DRUG-COATED BALLOON HELPING IN REDUCING RESTENOSIS
    • 5.16.2 CASE STUDY 2: IMPROVED OUTCOMES WITH TERUMO'S MISAGO STENT
  • 5.17 UNMET NEEDS AND END-USER EXPECTATIONS
    • 5.17.1 UNMET NEEDS
    • 5.17.2 END-USER EXPECTATIONS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI ON PERIPHERAL VASCULAR DEVICES MARKET

6 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION

7 ANGIOPLASTY STENTS MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 DRUG-ELUTING STENTS
    • 7.2.1 DRUG-ELUTING STENTS TO WITNESS HIGHER ADOPTION
  • 7.3 BARE-METAL STENTS
    • 7.3.1 BARE-METAL STENTS, BY DELIVERY PLATFORM
      • 7.3.1.1 Balloon-expandable stents
        • 7.3.1.1.1 Better radial strength and ease of deployment to drive usage
      • 7.3.1.2 Self-expandable stents
        • 7.3.1.2.1 Flexibility, tolerance, and support for vessel movement and compression to propel market

8 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
    • 8.2.1 RISING PREVALENCE AND NEED FOR TREATMENT TO DRIVE MARKET
  • 8.3 THORACIC AORTIC ANEURYSM STENT GRAFTS
    • 8.3.1 INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO PROPEL ADOPTION

9 CATHETERS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 ANGIOGRAPHY CATHETERS
    • 9.2.1 ANGIOGRAPHY CATHETERS TO DOMINATE CATHETERS MARKET
  • 9.3 GUIDING CATHETERS
    • 9.3.1 GROWING NUMBER OF TARGET PROCEDURES TO DRIVE MARKET
  • 9.4 IVUS/OCT CATHETERS
    • 9.4.1 IVUS/OCT CATHETERS SEGMENT TO REGISTER HIGHEST GROWTH

10 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE

  • 10.1 INTRODUCTION
  • 10.2 RETRIEVABLE FILTERS
    • 10.2.1 RETRIEVABLE FILTERS SEGMENT TO REGISTER HIGHER GROWTH
  • 10.3 PERMANENT FILTERS
    • 10.3.1 RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER SALES

11 ANGIOPLASTY BALLOONS MARKET, BY TYPE

  • 11.1 INTRODUCTION
  • 11.2 OLD/NORMAL BALLOONS
    • 11.2.1 OLD/NORMAL BALLOONS TO DOMINATE ANGIOPLASTY BALLOONS MARKET
  • 11.3 DRUG-ELUTING BALLOONS
    • 11.3.1 DRUG-ELUTING BALLOONS TO WITNESS HIGHEST GROWTH
  • 11.4 CUTTING & SCORING BALLOONS
    • 11.4.1 PREFERENCE FOR MEDICATION AS PRIMARY TREATMENT FOR ATHEROSCLEROSIS TO RESTRAIN ADOPTION

12 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE

  • 12.1 INTRODUCTION
  • 12.2 ATHERECTOMY DEVICES
    • 12.2.1 INCREASING INCIDENCE OF ATHEROSCLEROSIS TO DRIVE MARKET
  • 12.3 THROMBECTOMY DEVICES
    • 12.3.1 GROWING DVT INCIDENCE TO DRIVE ADOPTION OF THROMBECTOMY DEVICES

13 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE

  • 13.1 INTRODUCTION
  • 13.2 EMBOLIC PROTECTION DEVICES
    • 13.2.1 INVESTMENTS IN TECHNOLOGICAL ADVANCEMENTS AND GROWING REGULATORY APPROVALS TO DRIVE MARKET
  • 13.3 CHRONIC TOTAL OCCLUSION DEVICES
    • 13.3.1 RISING SUPPORT FOR DEVICE DEVELOPMENT TO DRIVE MARKET

14 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

  • 14.1 INTRODUCTION
  • 14.2 GUIDEWIRES
    • 14.2.1 GUIDEWIRES TO HOLD LARGEST MARKET SHARE
  • 14.3 VASCULAR CLOSURE DEVICES
    • 14.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
  • 14.4 INTRODUCER SHEATHS
    • 14.4.1 POTENTIAL FOR REDUCING ARTERIAL DAMAGE TO DRIVE ADOPTION
  • 14.5 BALLOON INFLATION DEVICES
    • 14.5.1 INTEGRATED TECHNOLOGIES AND RISING NUMBER OF TARGET PROCEDURES TO PROPEL ADOPTION

15 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 15.2.2 US
      • 15.2.2.1 Favorable reimbursement scenario to contribute to growth
    • 15.2.3 CANADA
      • 15.2.3.1 Increasing cases of chronic conditions to fuel market
  • 15.3 EUROPE
    • 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 15.3.2 GERMANY
      • 15.3.2.1 Statutory health insurance policy to support growth
    • 15.3.3 FRANCE
      • 15.3.3.1 Growing geriatric population to drive market
    • 15.3.4 UK
      • 15.3.4.1 Increasing volume of coronary angioplasty procedures to sustain growth
    • 15.3.5 SPAIN
      • 15.3.5.1 Growing cases of diabetes and obesity to boost market
    • 15.3.6 ITALY
      • 15.3.6.1 Increasing prevalence of atherosclerotic cardiovascular disease to spur growth
    • 15.3.7 REST OF EUROPE
  • 15.4 ASIA PACIFIC
    • 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 15.4.2 JAPAN
      • 15.4.2.1 Large geriatric population to ensure sustained demand
    • 15.4.3 CHINA
      • 15.4.3.1 Growing incidence of lifestyle diseases to fuel market
    • 15.4.4 INDIA
      • 15.4.4.1 Rising prevalence of target diseases and growing healthcare expenditure to propel market
    • 15.4.5 AUSTRALIA
      • 15.4.5.1 High prevalence of cardiovascular and peripheral artery diseases to drive market
    • 15.4.6 SOUTH KOREA
      • 15.4.6.1 Rising rates of chronic diseases to boost market
    • 15.4.7 REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    • 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 15.5.2 BRAZIL
      • 15.5.2.1 Rising healthcare expenditure to aid growth
    • 15.5.3 MEXICO
      • 15.5.3.1 Increasing prevalence of cardiovascular diseases to spur growth
    • 15.5.4 COLOMBIA
      • 15.5.4.1 Growing incidence of peripheral artery diseases to expedite growth
    • 15.5.5 ARGENTINA
      • 15.5.5.1 Increasing prevalence of peripheral artery diseases to support market growth
    • 15.5.6 REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST & AFRICA
    • 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 15.6.2 GCC COUNTRIES
      • 15.6.2.1 Rising cases of hypertension and associated cardiovascular diseases to drive market
    • 15.6.3 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

  • 16.1 INTRODUCTION
  • 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 16.3 REVENUE ANALYSIS
  • 16.4 MARKET SHARE ANALYSIS
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 16.5.1 STARS
    • 16.5.2 EMERGING LEADERS
    • 16.5.3 PERVASIVE PLAYERS
    • 16.5.4 PARTICIPANTS
    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 16.5.5.1 Company footprint
      • 16.5.5.2 Type footprint
      • 16.5.5.3 Region footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 16.6.1 PROGRESSIVE COMPANIES
    • 16.6.2 DYNAMIC COMPANIES
    • 16.6.3 RESPONSIVE COMPANIES
    • 16.6.4 STARTING BLOCKS
    • 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 16.7 BRAND/PRODUCT COMPARISON
  • 16.8 COMPANY VALUATION AND FINANCIAL METRICS
    • 16.8.1 FINANCIAL METRICS
    • 16.8.2 COMPANY VALUATION
  • 16.9 COMPETITIVE SCENARIO
    • 16.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 16.9.2 DEALS

17 COMPANY PROFILES

  • 17.1 KEY PLAYERS
    • 17.1.1 BOSTON SCIENTIFIC CORPORATION
      • 17.1.1.1 Business overview
      • 17.1.1.2 Products offered
      • 17.1.1.3 Recent developments
        • 17.1.1.3.1 Product approvals
        • 17.1.1.3.2 Deals
        • 17.1.1.3.3 Other developments
      • 17.1.1.4 MnM view
        • 17.1.1.4.1 Right to win
        • 17.1.1.4.2 Strategic choices
        • 17.1.1.4.3 Weaknesses and competitive threats
    • 17.1.2 MEDTRONIC
      • 17.1.2.1 Business overview
      • 17.1.2.2 Products offered
      • 17.1.2.3 Recent developments
        • 17.1.2.3.1 Product approvals
        • 17.1.2.3.2 Deals
      • 17.1.2.4 MnM view
        • 17.1.2.4.1 Right to win
        • 17.1.2.4.2 Strategic choices
        • 17.1.2.4.3 Weaknesses and competitive threats
    • 17.1.3 ABBOTT
      • 17.1.3.1 Business overview
      • 17.1.3.2 Products offered
      • 17.1.3.3 Recent developments
        • 17.1.3.3.1 Product launches
        • 17.1.3.3.2 Deals
      • 17.1.3.4 MnM view
        • 17.1.3.4.1 Right to win
        • 17.1.3.4.2 Strategic choices made
        • 17.1.3.4.3 Weaknesses and competitive threats
    • 17.1.4 BECTON, DICKINSON AND COMPANY
      • 17.1.4.1 Business overview
      • 17.1.4.2 Products offered
      • 17.1.4.3 Recent developments
        • 17.1.4.3.1 Product launches and approvals
        • 17.1.4.3.2 Deals
        • 17.1.4.3.3 Other developments
      • 17.1.4.4 MnM view
        • 17.1.4.4.1 Right to win
        • 17.1.4.4.2 Strategic choices
        • 17.1.4.4.3 Weaknesses and competitive threats
    • 17.1.5 TERUMO CORPORATION
      • 17.1.5.1 Business overview
      • 17.1.5.2 Products offered
      • 17.1.5.3 Recent developments
        • 17.1.5.3.1 Product launches
      • 17.1.5.4 MnM view
        • 17.1.5.4.1 Right to win
        • 17.1.5.4.2 Strategic choices
        • 17.1.5.4.3 Weaknesses and competitive threats
    • 17.1.6 B. BRAUN SE
      • 17.1.6.1 Business overview
      • 17.1.6.2 Products offered
    • 17.1.7 MERIT MEDICAL SYSTEMS
      • 17.1.7.1 Business overview
      • 17.1.7.2 Products offered
      • 17.1.7.3 Recent developments
        • 17.1.7.3.1 Product launches
    • 17.1.8 PENUMBRA, INC.
      • 17.1.8.1 Business overview
      • 17.1.8.2 Products offered
      • 17.1.8.3 Recent developments
        • 17.1.8.3.1 Product launches and approvals
    • 17.1.9 KONINKLIJKE PHILIPS NV
      • 17.1.9.1 Business overview
      • 17.1.9.2 Products offered
      • 17.1.9.3 Recent developments
        • 17.1.9.3.1 Product approvals
        • 17.1.9.3.2 Deals
    • 17.1.10 STRYKER
      • 17.1.10.1 Business overview
      • 17.1.10.2 Products offered
    • 17.1.11 CORDIS
      • 17.1.11.1 Business overview
      • 17.1.11.2 Products offered
      • 17.1.11.3 Recent developments
        • 17.1.11.3.1 Product approvals
        • 17.1.11.3.2 Other developments
    • 17.1.12 COOK
      • 17.1.12.1 Business overview
      • 17.1.12.2 Products offered
      • 17.1.12.3 Recent developments
        • 17.1.12.3.1 Deals
    • 17.1.13 W. L. GORE & ASSOCIATES, INC.
      • 17.1.13.1 Business overview
      • 17.1.13.2 Products offered
      • 17.1.13.3 Recent developments
        • 17.1.13.3.1 Product approvals
    • 17.1.14 BIOSENSORS INTERNATIONAL GROUP, LTD.
      • 17.1.14.1 Business overview
      • 17.1.14.2 Products offered
    • 17.1.15 IVASCULAR
      • 17.1.15.1 Business overview
      • 17.1.15.2 Products offered
    • 17.1.16 BIOTRONIK
      • 17.1.16.1 Business overview
      • 17.1.16.2 Products offered
      • 17.1.16.3 Recent developments
        • 17.1.16.3.1 Product launches
    • 17.1.17 ENDOLOGIX
      • 17.1.17.1 Business overview
      • 17.1.17.2 Products offered
    • 17.1.18 ENDOCOR GMBH & CO., KG
      • 17.1.18.1 Business overview
      • 17.1.18.2 Products offered
  • 17.2 OTHER PLAYERS
    • 17.2.1 MERIL LIFE SCIENCES PVT. LTD.
    • 17.2.2 ALVIMEDICA
    • 17.2.3 CARDIONOVUM GMBH
    • 17.2.4 SMT
    • 17.2.5 MEDINOL
    • 17.2.6 ANDRAMED GMBH
    • 17.2.7 REX MEDICAL
    • 17.2.8 QMD INC.
    • 17.2.9 BROSMED MEDICAL CO., LTD.
    • 17.2.10 ELIXIR MEDICAL

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 PERIPHERAL VASCULAR DEVICES MARKET: ASSUMPTION ANALYSIS
  • TABLE 3 PERIPHERAL VASCULAR DEVICES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030
  • TABLE 5 US: REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES
  • TABLE 6 DIABETIC POPULATION, BY REGION, 2019 VS. 2030
  • TABLE 7 TOP 10 COUNTRIES WITH HIGHEST SMOKING RATE (2021)
  • TABLE 8 OBESITY RATE, BY COUNTRY (2022)
  • TABLE 9 PERIPHERAL VASCULAR DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PERIPHERAL VASCULAR DEVICES
  • TABLE 11 KEY BUYING CRITERIA FOR PERIPHERAL VASCULAR DEVICES
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 HS CODES FOR PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 18 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 19 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 20 AVERAGE SELLING PRICE TREND OF PERIPHERAL VASCULAR DEVICES, BY REGION, BY TYPE 2021-2023 (USD)
  • TABLE 21 AVERAGE SELLING PRICE OF PERIPHERAL VASCULAR DEVICE, BY KEY PLAYER (2023)
  • TABLE 22 REIMBURSEMENT ANALYSIS FOR PERIPHERAL VASCULAR PROCEDURES
  • TABLE 23 DETAILED LIST OF KEY CONFERENCES AND EVENTS
  • TABLE 24 UNMET NEEDS: PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 25 END-USER EXPECTATIONS: PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 26 AI INTEGRATION: PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 27 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 28 ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 BARE-METAL STENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM, 2022-2029 (USD MILLION)
  • TABLE 33 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 SELF-EXPANDABLE STENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 36 EVAR STENT GRAFTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 AAA STENT GRAFTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 TAA STENT GRAFTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 40 CATHETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 GUIDING CATHETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 IVUS/OCT CATHETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 45 INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 49 ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 OLD/NORMAL BALLOONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 DRUG-ELUTING BALLOONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 CUTTING & SCORING BALLOONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 54 PLAQUE MODIFICATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 58 EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 GUIDEWIRES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 INTRODUCER SHEATHS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 BALLOON INFLATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 US: MACROECONOMIC INDICATORS
  • TABLE 77 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 US: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 US: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 85 CANADA: MACROECONOMIC INDICATORS
  • TABLE 86 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 CANADA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 CANADA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 EUROPE: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 104 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 GERMANY: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 GERMANY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 113 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 FRANCE: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 FRANCE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 UK: MACROECONOMIC INDICATORS
  • TABLE 122 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION
  • TABLE 123 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 UK: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 UK: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 131 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 SPAIN: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 SPAIN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 ITALY: MACROECONOMIC INDICATORS
  • TABLE 140 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 ITALY: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 ITALY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION)
  • TABLE 149 REST OF EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 REST OF EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 REST OF EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 REST OF EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 REST OF EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 JAPAN: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 JAPAN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION
  • TABLE 175 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 CHINA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 CHINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 INDIA: MACROECONOMIC INDICATORS
  • TABLE 183 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 INDIA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 INDIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 192 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 AUSTRALIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 AUSTRALIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 201 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 SOUTH KOREA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 SOUTH KOREA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 SOUTH KOREA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 SOUTH KOREA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 SOUTH KOREA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 227 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 229 BRAZIL: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 BRAZIL: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 236 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 237 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 MEXICO: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 MEXICO: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 COLOMBIA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 247 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 COLOMBIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 250 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 253 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 ARGENTINA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 ARGENTINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 REST OF LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 GCC COUNTRIES: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 293 PERIPHERAL VASCULAR DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 294 PERIPHERAL VASCULAR DEVICES MARKET: TYPE FOOTPRINT
  • TABLE 295 PERIPHERAL VASCULAR DEVICES MARKET: REGION FOOTPRINT
  • TABLE 296 PERIPHERAL VASCULAR DEVICES MARKET: KEY STARTUPS/SMES
  • TABLE 297 PERIPHERAL VASCULAR DEVICES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 298 PERIPHERAL VASCULAR DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 299 PERIPHERAL VASCULAR DEVICES MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 300 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 301 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 302 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021- AUGUST 2024
  • TABLE 303 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 304 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021- AUGUST 2024
  • TABLE 305 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 306 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 307 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 308 MEDTRONIC: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 309 ABBOTT: COMPANY OVERVIEW
  • TABLE 310 ABBOTT: PRODUCTS OFFERED
  • TABLE 311 ABBOTT: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 312 ABBOTT: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 313 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 314 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 315 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 316 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 317 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, JANUARY 2021- AUGUST 2024
  • TABLE 318 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 319 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 320 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 321 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 322 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 323 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 324 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 325 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 326 PENUMBRA, INC.: COMPANY OVERVIEW
  • TABLE 327 PENUMBRA, INC.: PRODUCTS OFFERED
  • TABLE 328 PENUMBRA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- AUGUST 2024
  • TABLE 329 KONINKLIJKE PHILIPS NV: COMPANY OVERVIEW
  • TABLE 330 KONINKLIJKE PHILIPS NV: PRODUCTS OFFERED
  • TABLE 331 KONINKLIJKE PHILIPS NV: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 332 KONINKLIJKE PHILIPS NV: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 333 STRYKER: COMPANY OVERVIEW
  • TABLE 334 STRYKER: PRODUCTS OFFERED
  • TABLE 335 CORDIS: COMPANY OVERVIEW
  • TABLE 336 CORDIS: PRODUCTS OFFERED
  • TABLE 337 CORDIS: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 338 CORDIS: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
  • TABLE 339 COOK: COMPANY OVERVIEW
  • TABLE 340 COOK: PRODUCTS OFFERED
  • TABLE 341 COOK: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 342 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
  • TABLE 343 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 344 W. L. GORE & ASSOCIATES, INC: PRODUCT APPROVALS, JANUARY 2021- AUGUST 2024
  • TABLE 345 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW
  • TABLE 346 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED
  • TABLE 347 IVASCULAR: COMPANY OVERVIEW
  • TABLE 348 IVASCULAR: PRODUCTS OFFERED
  • TABLE 349 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 350 BIOTRONIK: PRODUCTS OFFERED
  • TABLE 351 BIOTRONIK: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 352 ENDOLOGIX: COMPANY OVERVIEW
  • TABLE 353 ENDOLOGIX: PRODUCTS OFFERED
  • TABLE 354 ENDOCOR GMBH & CO., KG: COMPANY OVERVIEW
  • TABLE 355 ENDOCOR GMBH & CO., KG: PRODUCTS OFFERED
  • TABLE 356 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 357 ALVIMEDICA: COMPANY OVERVIEW
  • TABLE 358 CARDIONOVUM GMBH: COMPANY OVERVIEW
  • TABLE 359 SMT: COMPANY OVERVIEW
  • TABLE 360 MEDINOL: COMPANY OVERVIEW
  • TABLE 361 ANDRAMED GMBH: COMPANY OVERVIEW
  • TABLE 362 REX MEDICAL: COMPANY OVERVIEW
  • TABLE 363 QMD INC.: COMPANY OVERVIEW
  • TABLE 364 BROSMED MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 365 ELIXIR MEDICAL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 6 TOP-DOWN APPROACH
  • FIGURE 7 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 8 PERIPHERAL VASCULAR DEVICES MARKET: CAGR PROJECTIONS (2024-2029)
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 EVAR STENT GRAFTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 CATHETERS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHIC SNAPSHOT OF PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 18 GROWING GERIATRIC POPULATION AND RISING INCREASE IN DISEASE PREVALENCE TO DRIVE MARKET
  • FIGURE 19 DRUG-ELUTING STENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 20 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 KEY TRENDS IN MARKET: TECHNOLOGICAL ADVANCEMENTS AND SHIFT TOWARD MINIMALLY INVASIVE SURGERIES
  • FIGURE 23 PERIPHERAL VASCULAR DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 24 PERIPHERAL VASCULAR DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 PERIPHERAL VASCULAR DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 PERIPHERAL VASCULAR DEVICES MARKET: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PERIPHERAL VASCULAR DEVICES
  • FIGURE 28 KEY BUYING CRITERIA FOR PERIPHERAL VASCULAR DEVICES
  • FIGURE 29 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014-MARCH 2024)
  • FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) PATENTS (JANUARY 2014- AUGUST 2024)
  • FIGURE 31 PERIPHERAL VASCULAR DEVICES MARKET: INVESTMENT & FUNDING SCENARIO (2018-2023)
  • FIGURE 32 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
  • FIGURE 34 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 35 REVENUE ANALYSIS FOR KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET (2019-2023)
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET (2023)
  • FIGURE 37 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 38 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 39 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 40 PERIPHERAL VASCULAR DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 44 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 45 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 46 BECTON, DICKISON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 47 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 49 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • FIGURE 50 PENUMBRA, INC.: COMPANY SNAPSHOT
  • FIGURE 51 KONINKLIJKE PHILIPS NV: COMPANY SNAPSHOT
  • FIGURE 52 STRYKER: COMPANY SNAPSHOT